CorMedix Inc.

CRMDNASDAQUSD
7.83 USD
0.02 (0.26%)🟢PRE MARKET (AS OF 04:02 AM EDT)
🟢Market: OPEN
Open?$7.93
High?$7.93
Low?$7.80
Prev. Close?$7.82
Volume?99
Avg. Volume?1.1M
VWAP?$7.83
Rel. Volume?0.00x
Bid / Ask
Bid?$6.76 × 100
Ask?$8.86 × 100
Spread?$2.10
Midpoint?$7.81
Valuation & Ratios
Market Cap?618.2M
Shares Out?79.1M
Float?70.9M
Float %?90.5%
P/E Ratio?3.79
P/B Ratio?1.53
EPS?$2.06
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?2.11Strong
Quick Ratio?1.94Adequate
Cash Ratio?0.83Adequate
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUED
Score
100/100
P/E?
3.8CHEAP
P/B?
1.53CHEAP
P/S?
1.98CHEAP
P/FCF?
3.6CHEAP
EV/EBITDA?
2.9CHEAP
EV/Sales?
1.52CHEAP
Returns & Efficiency
ROE?
40.2%STRONG
ROA?
19.7%STRONG
Cash Flow & Enterprise
FCF?$172.8M
Enterprise Value?$474.5M
Fundamentals ratios updated end of day
xxx
Related Companies
Loading...
News
Profile
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
Employees
191
Market Cap
586.6M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2010-05-13
Address
389 INTERPACE PKWY, SUITE 450
PARSIPPANY, NJ 07054
Phone: 908-517-9500